Ocimum Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 3.10 M
as on 11-07-2024
- Paid Up Capital ₹ 3.10 M
as on 11-07-2024
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.05 Cr
as on 11-07-2024
- Satisfied Charges ₹ 1.60 Cr
as on 11-07-2024
- Revenue -20.91%
(FY 2020)
- Profit -4.24%
(FY 2020)
- Ebitda 53.15%
(FY 2020)
- Net Worth 20.41%
(FY 2020)
- Total Assets 149.61%
(FY 2020)
About Ocimum Life Sciences
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.10 M and a paid-up capital of Rs 3.10 M.
The company currently has active open charges totaling ₹3.05 Cr. The company has closed loans amounting to ₹1.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nidichenametla Ajay, Thirupathireddy Yalluri, Kalyani Nidichenametla, and One other member serve as directors at the Company.
- CIN/LLPIN
U24240TG2012PTC083812
- Company No.
083812
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Oct 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Ocimum Life Sciences Private Limited offer?
Ocimum Life Sciences Private Limited offers a wide range of products and services, including Organic and Inorganic Solvents, Ketones.
Who are the key members and board of directors at Ocimum Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivas Nidichenametla  | Managing Director | 23-Oct-2012 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nidichenametla Ajay | Director | 10-Apr-2024 | Current |
| Thirupathireddy Yalluri | Director | 10-Apr-2024 | Current |
| Kalyani Nidichenametla | Director | 23-Oct-2012 | Current |
Financial Performance of Ocimum Life Sciences.
Ocimum Life Sciences Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 20.91% decrease. The company also saw a slight decrease in profitability, with a 4.24% decrease in profit. The company's net worth Soared by an impressive increase of 20.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ocimum Life Sciences?
In 2019, Ocimum Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Enaaar Life Sciences Private LimitedActive 4 years 10 monthsKalyani Nidichenametla and Srinivas Nidichenametla are mutual person
- Mana Effluent Treatment Plant LimitedActive 12 years 11 months
Srinivas Nidichenametla is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 07 Mar 2022 | ₹0.79 M | Open |
Others Creation Date: 28 Jan 2022 | ₹1.48 Cr | Open |
Others Creation Date: 23 Nov 2021 | ₹0.57 M | Open |
How Many Employees Work at Ocimum Life Sciences?
Unlock and access historical data on people associated with Ocimum Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ocimum Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ocimum Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
